NCT00246584View on ClinicalTrials.gov

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

October 31, 2004

Conditions

Hypertension

Interventions

DRUG

SPP100

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY